Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2020
Theravance Biopharma appoints Deepika R. Pakianathan to its board
Theravance Biopharma announced the appointment of Deepika R. Pakianathan, Ph.D. to its board of directors.
2020
Theravance Biopharma prices public share offering
Theravance Biopharma announced pricing of an underwritten public offering of 5.5 million ordinary shares at $27 per share; the offering was expected to close on February 14, subject to customary conditions.